Bimeda has announced the launch of Tetroxy Vet injection (200mg/ml oxytetracycline), a POM-V indicated for the treatment and control of diseases caused by, or associated with, organisms sensitive to Oxytetracycline in cattle, sheep and pigs.

James Hutchings, Head of Sales for Bimeda UK, said: "The launch of Tetroxy Vet highlights our ongoing commitment to providing UK veterinarians with a choice of high quality veterinary pharmaceuticals at a fair price."

Bimeda says the benefits of Tetroxy Vet include:

• High syringe-ability: the product injects well event at cold temperatures.
• Flexibility: Tetroxy Vet is licensed for use in cattle, sheep and pigs and can be administered to lactating animals
• Fast-acting, yet long-acting: Tetroxy Vet provides rapid initial blood levels of oxytetracycline, followed by a long-acting effect.

Tetroxy Vet is available in a 100ml pack size.

PS: Whilst you're here, take a moment to see our latest job opportunities for vets.